LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Olanzapine 100 mg  | ≥98%

LKT Laboratories, Inc.

AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mAChR, α1/2-adrenergic antagonist.

More Information Supplier Page

×

Olanzapine

Olanzapine 250 mg  | ≥98%

LKT Laboratories, Inc.

AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mAChR, α1/2-adrenergic antagonist.

More Information Supplier Page

×

Olanzapine

Olanzapine 1 g  | ≥98%

LKT Laboratories, Inc.

AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mAChR, α1/2-adrenergic antagonist.

More Information Supplier Page

×

Olanzapine

Olaparib 25 mg  | ≥98%

LKT Laboratories, Inc.

PARP1/2 inhibitor.

More Information Supplier Page

×

Olaparib

Olaparib 5 mg  | ≥98%

LKT Laboratories, Inc.

PARP1/2 inhibitor.

More Information Supplier Page

×

Olaparib

Olaparib 10 mg  | ≥98%

LKT Laboratories, Inc.

PARP1/2 inhibitor.

More Information Supplier Page

×

Olaparib

Oleanolic Acid 100 mg  | ≥98%

LKT Laboratories, Inc.

Triterpenoid found in Vigna angularis and Trigonella foenum-graecum.

More Information Supplier Page

×

Oleanolic Acid

Oleanolic Acid 500 mg  | ≥98%

LKT Laboratories, Inc.

Triterpenoid found in Vigna angularis and Trigonella foenum-graecum.

More Information Supplier Page

×

Oleanolic Acid

Oleanolic Acid 1 g  | ≥98%

LKT Laboratories, Inc.

Triterpenoid found in Vigna angularis and Trigonella foenum-graecum.

More Information Supplier Page

×

Oleanolic Acid

Oligomycin 5 mg  | ≥97%

LKT Laboratories, Inc.

Mixture of oligomycins A, B, C; oxidative phosphorylation inhibitor, potential Na+/K+ ATPase inhibitor.

More Information Supplier Page

×

Oligomycin

Oligomycin 10 mg  | ≥97%

LKT Laboratories, Inc.

Mixture of oligomycins A, B, C; oxidative phosphorylation inhibitor, potential Na+/K+ ATPase inhibitor.

More Information Supplier Page

×

Oligomycin

Oligomycin 1 mg  | ≥97%

LKT Laboratories, Inc.

Mixture of oligomycins A, B, C; oxidative phosphorylation inhibitor, potential Na+/K+ ATPase inhibitor.

More Information Supplier Page

×

Oligomycin

Oligomycin A 1 mg  | ≥97%

LKT Laboratories, Inc.

Macrolide; F1F0 ATP synthase inhibitor.

More Information Supplier Page

×

Oligomycin A

Oligomycin A 5 mg  | ≥97%

LKT Laboratories, Inc.

Macrolide; F1F0 ATP synthase inhibitor.

More Information Supplier Page

×

Oligomycin A

Oligomycin B 1 mg  | ≥97%

LKT Laboratories, Inc.

Macrolide; F1F0 ATP synthase inhibitor.

More Information Supplier Page

×

Oligomycin B

Oligomycin B 5 mg  | ≥97%

LKT Laboratories, Inc.

Macrolide; F1F0 ATP synthase inhibitor.

More Information Supplier Page

×

Oligomycin B

Olmesartan Medoxomil 25 mg  | ≥98%

LKT Laboratories, Inc.

AT1 inhibitor.

More Information Supplier Page

×

Olmesartan Medoxomil

Olmesartan Medoxomil 100 mg  | ≥98%

LKT Laboratories, Inc.

AT1 inhibitor.

More Information Supplier Page

×

Olmesartan Medoxomil

Olmesartan Medoxomil 250 mg  | ≥98%

LKT Laboratories, Inc.

AT1 inhibitor.

More Information Supplier Page

×

Olmesartan Medoxomil

Olomoucine 25 mg  | ≥98%

LKT Laboratories, Inc.

Purine derivative; CDK inhibitor.

More Information Supplier Page

×

Olomoucine

Olomoucine 100 mg  | ≥98%

LKT Laboratories, Inc.

Purine derivative; CDK inhibitor.

More Information Supplier Page

×

Olomoucine

Olomoucine 5 mg  | ≥98%

LKT Laboratories, Inc.

Purine derivative; CDK inhibitor.

More Information Supplier Page

×

Olomoucine

Olopatadine Hydrochloride 10 mg  | ≥99%

LKT Laboratories, Inc.

Mast cell stabilizer; histamine H1/2/3 antagonist.

More Information Supplier Page

×

Olopatadine Hydrochloride

Olopatadine Hydrochloride 25 mg  | ≥99%

LKT Laboratories, Inc.

Mast cell stabilizer; histamine H1/2/3 antagonist.

More Information Supplier Page

×

Olopatadine Hydrochloride

Olopatadine Hydrochloride 100 mg  | ≥99%

LKT Laboratories, Inc.

Mast cell stabilizer; histamine H1/2/3 antagonist.

More Information Supplier Page

×

Olopatadine Hydrochloride

Olsalazine Sodium 25 mg  | ≥98%

LKT Laboratories, Inc.

5-Aminosalicylate prodrug, NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Olsalazine Sodium

Olsalazine Sodium 100 mg  | ≥98%

LKT Laboratories, Inc.

5-Aminosalicylate prodrug, NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Olsalazine Sodium

Olsalazine Sodium 250 mg  | ≥98%

LKT Laboratories, Inc.

5-Aminosalicylate prodrug, NSAID; COX-1/2 inhibitor.

More Information Supplier Page

×

Olsalazine Sodium

Oltipraz 500 mg  | ≥98%

LKT Laboratories, Inc.

Antioxidant; Nrf2 activator.

More Information Supplier Page

×

Oltipraz

Oltipraz 1 g  | ≥98%

LKT Laboratories, Inc.

Antioxidant; Nrf2 activator.

More Information Supplier Page

×

Oltipraz

Oltipraz 250 mg  | ≥98%

LKT Laboratories, Inc.

Antioxidant; Nrf2 activator.

More Information Supplier Page

×

Oltipraz

Omeprazole 1 g  | ≥98%

LKT Laboratories, Inc.

H+/K+ ATPase inhibitor.

More Information Supplier Page

×

Omeprazole

Omeprazole 5 g  | ≥98%

LKT Laboratories, Inc.

H+/K+ ATPase inhibitor.

More Information Supplier Page

×

Omeprazole

Omeprazole 10 g  | ≥98%

LKT Laboratories, Inc.

H+/K+ ATPase inhibitor.

More Information Supplier Page

×

Omeprazole

Omeprazole 500 mg  | ≥98%

LKT Laboratories, Inc.

H+/K+ ATPase inhibitor.

More Information Supplier Page

×

Omeprazole

Ondansetron Hydrochloride Dihydrate 100 mg  | ≥98%

LKT Laboratories, Inc.

5-HT3 antagonist.

More Information Supplier Page

×

Ondansetron Hydrochloride Dihydrate

Ondansetron Hydrochloride Dihydrate 500 mg  | ≥98%

LKT Laboratories, Inc.

5-HT3 antagonist.

More Information Supplier Page

×

Ondansetron Hydrochloride Dihydrate

Opioid Receptor Antagonist Ac-RFMWMK-NH2 1 mg  | ≥98%

LKT Laboratories, Inc.

Peptide; μ/δ/κ-OR inhibitor.

More Information Supplier Page

×

Opioid Receptor Antagonist Ac-RFMWMK-NH2

Orbifloxacin 100 mg  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor.

More Information Supplier Page

×

Orbifloxacin

Orbifloxacin 5 g  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor.

More Information Supplier Page

×

Orbifloxacin

Orbifloxacin 500 mg  | ≥98%

LKT Laboratories, Inc.

Fluoroquinolone; bacterial DNA gyrase inhibitor.

More Information Supplier Page

×

Orbifloxacin

Orexin B, human 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous peptide neurotransmitter, involved in circadian rhythms and feeding behaviors; OX2 agonist.

More Information Supplier Page

×

Orexin B, human

Oridonin 5 mg  | ≥98%

LKT Laboratories, Inc.

Diterpenoid found in Rabdosia rubescens; potential HSP70 activator.

More Information Supplier Page

×

Oridonin

Oridonin 25 mg  | ≥98%

LKT Laboratories, Inc.

Diterpenoid found in Rabdosia rubescens; potential HSP70 activator.

More Information Supplier Page

×

Oridonin

Oridonin 100 mg  | ≥98%

LKT Laboratories, Inc.

Diterpenoid found in Rabdosia rubescens; potential HSP70 activator.

More Information Supplier Page

×

Oridonin

Orlistat 100 mg  | ≥98%

LKT Laboratories, Inc.

Fatty acid synthase inhibitor.

More Information Supplier Page

×

Orlistat

Orlistat 500 mg  | ≥98%

LKT Laboratories, Inc.

Fatty acid synthase inhibitor.

More Information Supplier Page

×

Orlistat

Orlistat 1 g  | ≥98%

LKT Laboratories, Inc.

Fatty acid synthase inhibitor.

More Information Supplier Page

×

Orlistat

Ornidazole 5 g  | ≥98%

LKT Laboratories, Inc.

5-Nitroimidazole derivative; genotoxic.

More Information Supplier Page

×

Ornidazole

Ornidazole 50 g  | ≥98%

LKT Laboratories, Inc.

5-Nitroimidazole derivative; genotoxic.

More Information Supplier Page

×

Ornidazole